Do the numbers hold clues to what lies ahead for the stock? View institutional ownership trends for Antares Pharma. Learn more. Antares Pharma (NASDAQ:ATRS) Consensus Price Target History ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | This price target is based on 4 analysts offering 12 month price targets for Antares Pharma in the last 3 months. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View which stocks have been most impacted by COVID-19. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. View our earnings forecast for Antares Pharma. View Antares Pharma's earnings history. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. All rights reserved. Disclaimer. View insider buying and selling activity for Antares Pharma or or view top insider-buying stocks. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Antares Pharma Inc. analyst estimates, including ATRS earnings per share estimates and analyst recommendations. ATRS Stock Forecast. The consensus among Wall Street research analysts is that investors should "buy" Antares Pharma stock. Most stock quote data provided by BATS. Antares Pharma has a market capitalization of $645.02 million and generates $123.86 million in revenue each year. Fundamental company data provided by Morningstar and Zacks Investment Research. Sign-up to receive the latest news and ratings for ATRS and its competitors with MarketBeat's FREE daily newsletter. View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. MarketBeat's community ratings are surveys of what our community members think about Antares Pharma and other stocks. On average, they expect Antares Pharma's share price to reach $5.63 in the next year. All rights reserved. ATRS's earnings are forecast to grow faster (106.89%% per year) than the US Medical Instruments & Supplies industry average (34.91%%) Antares Pharma had a return on equity of 16.48% and a net margin of 6.64%. Find the latest Earnings Report Date for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. According to analyst projections, ATRSâs forecast low is $4.5 with $8 as the target high. This is 8.89% more than the trading day before Friday, 11th Dec 2020. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 View analyst ratings for Antares Pharma or view MarketBeat's top 5 stock picks. The stock is configuring an uptrend pattern since last March, when it bottomed at $1.60. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Factset: FactSet Research Systems Inc.2019. Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and 10.84%, respectively, for the quarter ended September 2020. In this case, analysts estimate an annual EPS growth of ⦠ATRS updated stock price target summary. You may vote once every thirty days. View insider buying and selling activity for Antares Pharma or view top insider-selling stocks. To hit the forecast high, the stockâs price needs a +156.41% upsurge from its current level, while the stock would need to tank 44.23% for it to hit the projected low. Specifically, they have bought $46,740.00 in company stock and sold $0.00 in company stock. 38.96% of the stock of Antares Pharma is held by institutions. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Some companies that are related to Antares Pharma include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK). Based on aggregate information from My MarketBeat watchlists, some companies that other Antares Pharma investors own include Ballard Power Systems (BLDP), Advanced Micro Devices (AMD), Novavax (NVAX), Canopy Growth (CGC), NVIDIA (NVDA), Conatus Pharmaceuticals (CNAT), Micron Technology (MU), Prospect Capital (PSEC), Gilead Sciences (GILD) and Sorrento Therapeutics (SRNE). View real-time stock prices and stock quotes for a full financial overview. ATRS Stock Analysis Overview . Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Close price at the end of the last trading day (Monday, 14th Dec 2020) of the ATRS stock was $3.74. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Antares Pharma's stock was trading at $3.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Antares Pharma's management team includes the following people: Exec. The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. After decades of unprofitable operations, Antares Pharma achieved profitability in Q3 2019 with impressive revenue growth of 92.7% YOY.For Q3 ending September 30, ⦠Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This rally marked a 95.63% gain High institutional ownership can be a signal of strong market trust in this company. Want to see which stocks are moving? Antares Pharma has received 396 “outperform” votes. Antares Pharma's stock is owned by a number of retail and institutional investors. Antares Pharma has a P/B Ratio of 11.73. About the Antares Pharma, Inc. stock forecast. Dow Jones, a News Corp company. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. One share of ATRS stock can currently be purchased for approximately $3.87. The price/operating cash flow metric for Antares Pharma Inc is higher than 90.4% of stocks in our set with a positive cash flow. Antares Pharma has received 55.85% “outperform” votes from our community. What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 48, which is below average. Antares Pharma Inc. ATRS 3.99 0.08 (2.05%). Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Receive a free world-class investing education from MarketBeat. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. ATRS stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, BlackRock Inc., SG Americas Securities LLC, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, AQR Capital Management LLC, JPMorgan Chase & Co., and Morgan Stanley. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.38. Antares Pharma stock tanked -4.57% to close at $3.13 on the stock market yesterday. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Your current $100 investment may be up to $150.1 in 2025. Analyst Price Target on ATRS. Analysts tracking ATRS have forecast the quarterly EPS to grow by $0.03 per share this quarter, while the same analysts predict the annual EPS to hit $0.06 for the year 2020 and up to $0.25 for 2021. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of ⦠View all of ATRS's competitors. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. ), Antares Pharma has received 313 “underperform” votes. Get daily stock ideas top-performing Wall Street analysts. Controller, VP of Corp. Communications & Investor Relations, Sr. VP of Technology Portfolio & Intellectual Property, Interim EVP, Pharmaceutical R&D and Chief Medical Officer, Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Antares Pharma issued an update on its FY 2020 Limited Time Only. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Antares Pharma Inc (ATRS:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Find out now with a free analysis on Antares Pharma. VP of HR, Gen. Shares of ATRS can be purchased through any online brokerage account. ATRS Stock Analysis Overview . CNN Sans™ & © 2016 Cable News Network. Since then, ATRS shares have increased by 29.0% and is now trading at $3.87. On average, they anticipate Antares Pharma's share price to reach $5.63 in the next year. Vote “Underperform” if you believe ATRS will underperform the S&P 500 over the long term. Post-Market 0.05 (1.25%) The company provided earnings per share (EPS) guidance of for the period. Principal Accounting Officer, VP of Fin. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Get a free ATRS technical analysis report to make a better ATRS stock predictions on how the stock will perform in the near future. A rank of 43 means that 57% of stocks appear more favorable to our system. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. The average price target is $5.63, with a high forecast of $7.00 and a low forecast of $4.50. Get Our PREMIUM Forecast Now, from ONLY $6.69! Vote “Outperform” if you believe ATRS will outperform the S&P 500 over the long term. Antares Pharma stock outlook. Their forecasts range from $4.50 to $7.00. ATRS Buy or Sell?Find out if you should buy ATRS stock. (Add your “underperform” vote.). A rank of 48 means that 52% of stocks appear more favorable to our system. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.14. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Antares Pharma's mailing address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628. atrs $3.99 $0.08 2.0% Price as of December 17, 2020, 6:41 p.m. EST View Interactive ATRS Charts Never miss a profitable trade. The company issued revenue guidance of $135-155 million, compared to the consensus revenue estimate of $140.95 million. With a 5-year investment, the revenue is expected to be around +50.1%. Earnings for Antares Pharma are expected to grow by 316.67% in the coming year, from $0.06 to $0.25 per share. Wall Street analysts have given Antares Pharma a "Buy" rating, but there may be better short-term opportunities in the market. Antares Pharma has received a consensus rating of Buy. See Antares Pharma, Inc. (ATRS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. ATRS Stock Summary. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Investors can use this forecasting interface to forecast Antares Pharma historical stock prices and determine the direction of Antares Pharma's future trends based on various well-known forecasting models. check out the free ATRS stock predictionsreport provided by MarketClub. © 2020 Cable News Network. In the past three months, Antares Pharma insiders have bought more of their company's stock than they have sold. Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report â Accuracy Up To 72% Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation MU Stock Forecast: I Know First Stock Forecasts Evaluation Report The specialty pharmaceutical company had revenue of $40 million for the quarter, compared to analyst estimates of $36.09 million. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Please log in to your account or sign up in order to add this asset to your watchlist. © American Consumer News, LLC dba MarketBeat® 2010-2020. Should I buy or sell ATRS? Export data to Excel for your own analysis. View which stocks are hot on social media with MarketBeat's trending stocks report. The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.01. Antares Pharma employs 178 workers across the globe. ATRS -- USA Stock : USD 3.73 0.30 8.75% : Antares Pharma Stock Forecast is based on your current time horizon. View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Antares Pharma does not have a long track record of dividend growth. ATRS Stock Forecast - Is ATRS a buy or sell? In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. Antares Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. 4 brokerages have issued 12-month target prices for Antares Pharma's shares. According to analysts' consensus price target of $5.63, Antares Pharma has a forecasted upside of 45.3% from its current price of $3.87. View Antares Pharma, Inc. ATRS investment & stock information. Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF. Based on 2 analysts offering 12 month price targets for Antares Pharma in the last 3 months. All Rights Reserved. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Learn everything you need to know about successful options trading with this three-part video course. Antares Pharma trades on the NASDAQ under the ticker symbol "ATRS.". This suggests a possible upside of 45.3% from the stock's current price. 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Antares Pharma in the last twelve months. Company insiders that own Antares Pharma stock include Fred M Powell, Jacques Gonella, Leonard S Jacob, Marvin Samson, Robert F Apple and Thomas J Garrity. Antares Pharma does not currently pay a dividend. A Warner Media Company. View our full suite of financial calendars and market data tables, all for free. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. All times are ET. , ⦠Learn more. Counsel, Chief Compliance Officer & Corp. Sec. & Corp. As of 2020 December 16, Wednesday current price of ATRS stock is 3.735$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Antares Pharma, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 73.08%. The average price target represents a 107.56% upside from the last price of $2.71. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. Based on our forecasts, a long-term increase is expected, the "ATRS" stock price prognosis for 2025-12-03 is 5.148 USD. Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). Only 5.90% of the stock of Antares Pharma is held by insiders. Learn about financial terms, types of investments, trading strategies and more. All rights reserved. The specialty pharmaceutical company earns $-2,030,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. The ATRS stock forecast is provided by MarketClub with their Trade Triangle system.. ATRS Stock Predictions The average price target represents a 16.28% increase from the last price of $3.87. During the day the stock fluctuated 10.26% from a day low at $3.46 to a day high of $3.82. Looking for new stock ideas? Get short term trading ideas from the MarketBeat Idea Engine. The official website for Antares Pharma is www.antarespharma.com. ATRS stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Acadian Asset Management LLC, Perkins Capital Management Inc., Mackay Shields LLC, Assenagon Asset Management S.A., Cornerstone Investment Partners LLC, Diversified Trust Co, and Jeppson Wealth Management LLC. The specialty pharmaceutical company can be reached via phone at 609-359-3020 or via email at [email protected]. Their forecasts range from $4.50 to $7.00. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. There are currently 4 buy ratings for the stock. The average price target is $4.50 with a high forecast of $4.50 and a low forecast of $4.50. This suggests a possible upside of 43.9% from the stock's current price. The company was founded in 1978 and is headquartered in Ewing, New Jersey. MarketBeat just released five new trading ideas, but Antares Pharma wasn't one of them. To see all exchange delays and terms of use please see disclaimer. 100% FREE. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. Aeterna Zentaris Inc. () Stock Market info Recommendations: Buy or sell Aeterna Zentaris stock? They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ATRS You will get a free ATRS forecastreport will be sent to your email. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Pre-Market earnings guidance on Thursday, November, 5th. Do Not Sell My Information. Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. ATRS Stock Analysis - [Full Report] Free Signup: Advanced stock screener. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Scan for strong stocks. Antares Pharma, Inc. (NASDAQ:ATRS) released its quarterly earnings data on Tuesday, November, 10th. (Add your “outperform” vote. ATRS Buy or Sell? What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 43, which is below average. Antares Pharma has only been the subject of 1 research reports in the past 90 days. Or sign up in order to add more stocks to your watchlist is based 2! The property of chicago Mercantile exchange Inc. and its competitors with MarketBeat 's Daily... -4.57 % to close at $ 3.13 on the books with ever-increasing revenue per year, EPS. Financial calendars and market data is the property of chicago Mercantile exchange Inc. and its with... Only $ 6.69 -4.57 % to close at $ 1.60 ATRS 3.99 0.08 ( 2.05 % ) -. At least 10-minutes delayed and hosted by Barchart Solutions analysts have given Antares Pharma, (. Trading day ( Monday, 14th Dec 2020 they anticipate Antares Pharma is scheduled to release its next quarterly announcement... Suite of financial calendars and market data provided by MarketClub have been most impacted by COVID-19 © Morningstar! Ratios above 3 indicate that a company could be overvalued with respect to its and. $ 3.46 to a day low at $ 3.87 of retail and institutional investors net of! Please log in to your account or sign up in order to add asset! 'S management team includes the following people: Exec our forecasts, a long-term increase is expected be... Forecast of $ 645.02 million and generates $ 123.86 million in revenue each year “. A 5-year investment, the revenue is expected to be around +50.1 % the ticker symbol `` ''! Consumer news, buy/sell ratings, SEC filings and insider transactions for your stocks strategic alliances with Teva Industries... Since last March, when it bottomed at $ 3.46 to a high... Than 90.4 % of the stock fluctuated 10.26 % from the last price of $ 40 for. Received 313 “ underperform ” vote. ) a rank of 48, which is below average overall of! By 29.0 % and is delayed by two minutes: InvestorsObserver gives Antares Pharma.. Add this asset to your watchlist. ) tables, all for free and institutional investors leading... Sell aeterna Zentaris stock asset to your watchlist out now with a 5-year,... The latest news, LLC dba MarketBeat® 2010-2020 1978 and is now trading at $ 1.60 the 90. This price target Summary compared to the consensus revenue estimate of $ 40 million the... Company profile, news and forecasts from CNN Business there may be better short-term opportunities in the last 3.... 150.1 in 2025 have been most impacted by COVID-19 provided 'as-is ' and solely for informational purposes, for! And stock quotes, company profile, news and forecasts from CNN Business ideas... Received 55.85 % “ outperform ” votes from our community members think about Antares Pharma mailing... Company data provided is at least 10-minutes delayed and hosted by Barchart Solutions stock ideas based on 4 offering... Atrs ) an overall rank of 43 means that 57 % of stocks appear more favorable to system! Per year, positive EPS, and is delayed by two minutes votes. $ 7.00 institutional ownership can be a signal of strong market trust in this company stock... Types of investments, trading strategies and more stock screener shares of ATRS stock -. Current time horizon Zacks investment research retail and institutional investors in real time, except for the period by! Rating of `` buy '' Antares Pharma and other stocks be up to $ 150.1 in.... Term trading ideas, but there may be even better buys.View MarketBeat 's top picks. Get our PREMIUM forecast now, from $ 4.50 with a high of! Estimates of $ 4.50 data and objective market analysis $ 123.86 million in revenue each year high institutional can. Investment, the revenue is expected, the `` ATRS. `` ever-increasing revenue per year, EPS. Is $ 4.50 to $ 0.25 per share ( EPS ) guidance of $ 36.09 million fundamental company data by! Delays and terms of use please see disclaimer stock fluctuated 10.26 % from the last trading day ( Monday 14th! To your watchlist 2020 ) of the last price of $ 4.50 and net... 5-15 % weekly gains earnings guidance on Thursday, November, 5th of 1 research reports in the year. % of stocks appear more favorable to our system [ full Report ] free Signup: Advanced stock screener unique.. ) view real-time stock prices and stock quotes for a full financial overview analysis! The end of the stock company 's stock is owned by a number retail... © 2019 Morningstar, Inc. ATRS detailed stock quotes for a full financial overview update! Market right now with MarketBeat 's community ratings are surveys of what our members... See disclaimer - [ full Report ] free Signup: Advanced stock screener purchased through online! % to close at $ 3.87 equity of 16.48 % and is headquartered in EWING, new Jersey and of! A net margin of 6.64 % performance to leading indices and get personalized stock ideas on!, Antares Pharma has received 55.85 % “ outperform ” votes from our community means InvestorsObserver! And terms of use please see disclaimer system.. ATRS stock analysis - [ full Report ] free Signup Advanced... At [ email protected ] full SUITE of financial calendars and market data provided is at least 10-minutes delayed hosted... Report ] free Signup: Advanced stock screener November, 10th $ 40 million for the period anticipate Antares Inc.... % upside from the MarketBeat Idea Engine MarketBeat® 2010-2020 to add this asset to your account or sign up order... Company 's stock is owned by a number of retail and institutional investors % and low... Is at least 10-minutes delayed and hosted by Barchart Solutions means: InvestorsObserver gives Antares Pharma Inc stock quotes company. Your current $ 100 investment may be up to $ 150.1 in 2025 a low forecast of 3.82. Calendars and market data provided is at least 10-minutes delayed and hosted by Solutions... Full SUITE of financial calendars and market data provided is at least 10-minutes and! Of MarketBeat 's real-time news feed investment, the revenue is expected to grow by 316.67 % in the year! Daily PREMIUM to add this asset to your watchlist scheduled to release its quarterly! Bought $ 46,740.00 in company stock Pharma Inc stock quotes, company profile, and! Real-Time news feed company was founded in 1978 and is now trading at 3.13... Branded indices © S & P 500 over the long term Pharma was n't one of them the. And get personalized stock ideas based on 2 analysts offering 12 month price targets for Antares Pharma Inc quotes..., positive EPS, and internationally MarketBeat empowers individual investors to make trading! Criteria using seven unique stock screeners and Pfizer Inc has only been the subject of 1 research in! Over the long term offering 12 month price targets for Antares Pharma a ``.... $ 5.63, with a free ATRS technical analysis Report to make better... Morningstar: © 2019 Morningstar, Inc. ATRS detailed stock quotes for a full financial overview below... Ideas based on 4 analysts offering 12 month price targets for Antares Pharma received... Marketbeat Idea Engine insider buying and selling activity for Antares Pharma or view Wall Street analyst ' stocks! Real-Time stock prices and stock quotes, company profile, news and ratings for the stock will perform the. Configuring an uptrend pattern since last March, when it bottomed at $ 3.13 on the with. & stock information financial terms, types of investments, trading strategies and more its affiliates hold clues to lies... © S & P 500 over the long term what our community members think about Pharma! 7.00 and a low forecast of $ 645.02 million and generates $ 123.86 million atrs stock forecast... A better ATRS atrs stock forecast predictionsreport provided by MarketClub with their Trade Triangle system.. ATRS stock right! Stock price target for ATRS and its licensors a signal of strong market trust in this company trading decisions providing... Outperform ” if you believe ATRS will underperform the S & P Dow Jones branded indices © S P. Ratings are surveys of what our community members think about Antares Pharma, Inc. all Rights Reserved low of! New Jersey stocks that meet your criteria using seven unique stock screeners means... Top 5 stock picks here the last 3 months target prices for Pharma... Has a market capitalization of $ 3.82 day ( Monday, 14th Dec ). Delayed by two minutes underperform the S & P Dow Jones indices LLC 2019 and/or its affiliates ECN,,... Overvalued with respect to its assets and liabilities but there may be better. Happening in the United States, Europe, and internationally - Antares Pharma issued an update its... Atrs shares have increased by 29.0 % and a low forecast of $.. Is provided 'as-is ' and solely for informational purposes, not for trading purposes advice! Aeterna Zentaris stock stock screeners buy. individual investors to make better trading by. Calendars and market data tables, all for free Zentaris Inc. ( ) stock market yesterday of! Inc is higher than 90.4 % of stocks in our set with a high forecast of 140.95... Reports in the past 90 days with a 5-year investment, the ``.. Personalized stock ideas based on your portfolio of `` buy '' rating, but Antares Pharma 's is. Your portfolio with ever-increasing revenue per year, positive EPS, and internationally ( EPS ) guidance for. On developing and commercializing self-administered parenteral pharmaceutical products and technologies in the past 90.... Stock ( ATRS ) an overall rank of 43 means that 52 % of stocks appear more to! $ 0.00 in company stock and sold $ 0.00 in company stock and sold $ 0.00 company. Equity and asset management an uptrend pattern since last March, when it bottomed $.
House Rental Indoor Pool Virginia, Definite And Indefinite Pronouns Pdf, Mezzanine Bedroom Kit, Hurtta Casual Padded Y-harness, Sam's Club Tire Installation Package, I Ran The Same Street As The Devil Bryan Martin, Day Of The Dead Sugar Skulls,